Quadrant Capital Group’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-261
| Closed | -$8.33K | – | 2749 |
|
|
2024
Q4 | $8.33K | Buy |
261
+222
| +569% | +$7.08K | ﹤0.01% | 2182 |
|
|
2024
Q3 | $1.13K | Sell |
39
-103
| -73% | -$2.97K | ﹤0.01% | 2577 |
|
|
2024
Q2 | $5.45K | Sell |
142
-38
| -21% | -$1.46K | ﹤0.01% | 2273 |
|
|
2024
Q1 | $10.6K | Buy |
180
+6
| +3% | +$353 | ﹤0.01% | 2083 |
|
|
2023
Q4 | $10.4K | Sell |
174
-33
| -16% | -$1.98K | ﹤0.01% | 2053 |
|
|
2023
Q3 | $7.88K | Buy |
207
+84
| +68% | +$3.2K | ﹤0.01% | 2050 |
|
|
2023
Q2 | $11.2K | Hold |
123
| – | – | ﹤0.01% | 1952 |
|
|
2023
Q1 | $8.11K | Buy |
+123
| New | +$8.11K | ﹤0.01% | 2110 |
|
|
2022
Q3 | – | Sell |
-84
| Closed | -$4K | – | 2630 |
|
|
2022
Q2 | $4K | Buy |
+84
| New | +$4K | ﹤0.01% | 2013 |
|
|
2021
Q4 | – | Sell |
-8
| Closed | – | – | 2496 |
|
|
2021
Q3 | $0 | Buy |
+8
| New | – | ﹤0.01% | 2492 |
|